Tectonic Therapeutic, Inc. (TECX)
NASDAQ · Healthcare
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $615.14M
- P/E ratio
- —
- EPS
- —
- Volume
- 139,334
- 52-week high
- —
- 52-week low
- —
- Open
- $32.63
- Day high
- $33.40
- Day low
- $31.38
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | — | -$74.15M | -$4.05 |
| 2024 | — | -$57.98M | -$6.83 |
| 2023 | — | -$42.82M | -$33.76 |
| 2022 | — | -$105.89M | -$2.42 |
| 2021 | — | -$119.13M | -$2.78 |
About Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.
- CEO
- Alise S. Reicin
- Employees
- 60
- Country
- US
- IPO date
- Jun 21, 2018
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Tectonic Therapeutic, Inc.'s stock price today?
- TECX is trading at $32.07 as of Jul 20, 2026.
- What is Tectonic Therapeutic, Inc.'s market cap?
- Tectonic Therapeutic, Inc. (TECX) has a market capitalization of $615.14M.
- Does Tectonic Therapeutic, Inc. pay a dividend?
- Tectonic Therapeutic, Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is Tectonic Therapeutic, Inc. in?
- Tectonic Therapeutic, Inc. operates in the Healthcare sector.